Cancer Cures Media ArticlesExcerpts of Key Cancer Cures Media Articles in Major Media
Note: Explore our full index to key excerpts of revealing major media news articles on several dozen engaging topics. And don't miss amazing excerpts from 20 of the most revealing news articles ever published.
In a study, researchers have found that long-term pot smokers were roughly 62 percent less likely to develop head and neck cancers than people who did not smoke pot. The new study featured 434 patients with head and neck cancers, which include tumors in the mouth, tongue, nose, sinuses, throat and lymph nodes in the neck, and 547 individuals without these cancers seen in the Greater Boston area from December 1999 to December 2003. After factoring out the impact of smoking, drinking, and other factors that might influence the results, smoking marijuana from once every two weeks to three times every two weeks, on average, was associated with about half the risk of head and neck cancer, compared with less frequent use. Those who took up pot smoking at an older age appeared to have less risk of these cancers than those who started it at a younger age. Compared to people who never smoked pot, those who began smoking marijuana between the ages of 15 and 19 years were 47 percent less likely to develop head and neck cancer, while users who began at age 20 or older had a 61 percent reduced risk, Kelsey and colleagues found. The authors note that chemicals in pot called cannabinoids have been shown to have potential antitumor effects. Other studies have linked marijuana use to a reduced risk of some cancers, such as cancer of the prostate, and now head and neck cancer. It's also been suggested that smoking pot may help stave off Alzheimer's disease and help combat weight loss associated with AIDS, and nausea and vomiting associated with chemotherapy in cancer patients.
Note: For a great nine-minute video presenting major media reports showing how marijuana is a very promising cancer treatment that is being suppressed, click here. For deeply revealing reports from reliable major media sources on health issues, click here.
Spontaneous tumor regressions are among the rarest and most mysterious events in medicine, with only several hundred cases in the literature that can be considered well documented. Regressions have most often been reported in melanoma and in kidney cancer. But the phenomenon may, in fact, be an everyday one, taking place beyond doctors' eyes. A recent study suggests that as many as 1 in 3 breast tumors may vanish on their own before being detected by a doctor. Why do some patients get lucky? Scientists are finding tantalizing evidence that the immune system, the body's defense against disease-causing microbes, kicks in to play a critical role in combating cancer. The evidence includes the fact that some unexplained remissions have occurred after infections, which may propel the immune system into high gear--possibly attacking the cancer tumor as well as the infection. The role of the immune system in controlling cancer has been hotly debated for decades--and indeed many scientists remain unconvinced. But Jedd D. Wolchok, an oncologist at New York's Memorial Sloan-Kettering Cancer Center, thinks there is a connection. A spontaneous remission, he says, is "either divine intervention or the immune system." While few researchers directly study such cases--they are far too rare--they provide hints of what the immune system might be able to do if we could harness it.
Note: The number of these cancer miracles are likely far more than suggested in this article. The problem is that most doctors ignore or consider them insignificant. For a most fascinating example of this, click here. For many exciting reports from major media sources describing potentially promising new cancer treatments, click here.
An extract from grape seeds can destroy cancer cells, US research suggests. In lab experiments, scientists found that the extract stimulated leukaemia cells to commit suicide. Within 24 hours, 76% of leukaemia cells exposed to the extract were killed off, while healthy cells were unharmed, Clinical Cancer Research reports. The study raises the possibility of new cancer treatments, but scientists said it was too early to recommend that people eat grapes to ward off cancer. Grape seeds contain a number of antioxidants, including resveratrol, which is known to have anti-cancer properties, as well as positive effect on the heart. Previous research has shown grapeseed extract has an effect on skin, breast, bowel, lung, stomach and prostate cancer cells in the laboratory. It can also reduce the size of breast tumours in rats and skin tumours in mice. However, the University of Kentucky study is the first to test its impact on a blood cancer. Lead researcher Professor Xianglin Shi said: "These results could have implications for the incorporation of agents such as grapeseed extract into prevention or treatment of haematological (blood) malignancies and possibly other cancers. What everyone seeks is an agent that has an effect on cancer cells but leaves normal cells alone, and this shows that grapeseed extract fits into this category."
Note: For lots more on promising new cancer research findings from major media sources, click here.
Cancer researchers have known for years that it was possible in rare cases for some cancers to go away on their own. There were occasional instances of melanomas and kidney cancers that just vanished. And neuroblastoma, a very rare childhood tumor, can go away without treatment. But these were mostly seen as oddities — an unusual pediatric cancer that might not bear on common cancers of adults, a smattering of case reports of spontaneous cures. And since almost every cancer that is detected is treated, it seemed impossible even to ask what would happen if cancers were left alone. Now, though, researchers say they have found a situation in Norway that has let them ask that question about breast cancer. And their new study, to be published Tuesday in The Archives of Internal Medicine, suggests that even invasive cancers may sometimes go away without treatment and in larger numbers than anyone ever believed. Robert M. Kaplan, the chairman of the department of health services at the School of Public Health at the University of California, Los Angeles, [is] persuaded by the analysis. The implications are potentially enormous, Dr. Kaplan said. If the results are replicated, he said, it could eventually be possible for some women to opt for so-called watchful waiting, monitoring a tumor in their breast to see whether it grows. “People have never thought that way about breast cancer,” he added. Dr. Kaplan and his colleague, Dr. Franz Porzsolt, an oncologist at the University of Ulm, said in an editorial that accompanied the study, “If the spontaneous remission hypothesis is credible, it should cause a major re-evaluation in the approach to breast cancer research and treatment.”
Note: For reports from major media sources on many hopeful new developments in the battle against cancer, click here.
There is an epidemic of cancer today. One in three Americans will be diagnosed with cancer, often before the age of 65. Since 1940, we have seen in Western societies a marked and rapid increase in common types of cancer. In fact, cancer in children and adolescents has been rising by 1 to 1.5 percent a year since the 1960's. And these are cancers for which there is no screening. For most common cancers - prostate, breast, colon, lung - rates are much higher in the West than in Asian countries. Yet Asians who emigrate to the United States catch up with the rates of Americans within one or two generations. While in Asia, Asians are protected not by their genes, but by their lifestyle. We continue to invest 97 percent of our cancer research funds in better treatments and early detection. Only 3 percent is invested in tackling causes. The World Cancer Research Fund published a report in 2007 concluding that a majority of cancer cases in Western societies could be avoided with life-style measures: 40 percent from changes in diet and physical activity (more vegetables and fruits, less sugar, less red meat, regular walking or the equivalent activity 30 minutes six times per week), 30 percent from smoking cessation, and about 10 percent from reduced alcohol consumption. We now even have data about how specific foods such as broccoli and cabbages, garlic and onions, green tea or the spice turmeric directly help kill cancer cells and reduce the growth of new blood vessels they need to develop into tumors.
Note: The author of this article, Dr. David Servan-Schreiber, is a clinical professor of psychiatry at the University of Pittsburgh and a founding board member of Doctors Without Borders, USA, and author of Anticancer - A new way of life. For an excellent, inspiring 10-minute video interview with this doctor, click here.
In a major breakthrough in the search for a cure for cancer, the first human trials are to begin using a technique that has already been shown to destroy the disease in mice. The trials are the culmination of years of research prompted by the discovery of a cancer-proof mouse by researchers almost a decade ago. More than 20 cancer patients will be given white blood cells with cancer-killing properties in an attempt to boost their immune system's fight against the deadly illness. The work stems from experiments into the metabolism of a humble laboratory mouse whose immunity to cancer defied the repeated attempts of scientists to kill it with high-level doses of cancer cells. White blood cells taken from the animal and its offspring were subsequently used to cure other mice of advanced cancers. The white blood cells destroyed the cancer cells but left normal cells alone. This discovery encouraged scientists to study how people might be helped to fight off cancer by being given a boost of white blood cells called granulocytes. Laboratory tests have since shown how human granulocytes can destroy cervical, prostate and breast cancer cells, provided sufficient numbers of cancer-killing granulocytes from healthy donors are used. Scientists are now confident that the treatment will prove just as successful in humans as it has been in mice. Hundreds of donors will be recruited for the new treatment – which is called leukocyte infusion therapy – and a process similar to platelet donation will be used to collect the granulocytes.
A man who had been given less than a year to live had a complete remission of advanced deadly skin cancer after an experimental treatment that revved up his immune system to fight the tumors. The 52-year-old patient's dramatic turnaround was the only success in a small study, leading doctors to be cautious in their enthusiasm. However, the treatment reported in ... The New England Journal of Medicine is being counted as the latest in a small series of successes involving immune-priming treatments against deadly skin cancers. "Immunotherapy has become the most promising approach" to late-stage, death-sentence skin cancers, said Dr. Darrell Rigel, a dermatology researcher at the New York University Cancer Institute in New York. About 20 years ago, some scientists discovered that immune cells could latch onto and attack skin cancers. "There's a long history behind all of this," said Dr. Steven Rosenberg of the National Cancer Institute. In recent experiments, Rosenberg and other researchers have focused on souping up a certain kind of immune system cell - the "killer T cells" that envelop and kill foreign agents. Scientists focused ... on specific helper T cells that are adept at locking onto a cancer cell and guiding the killer cells to their target. The researchers drew blood from patients, located the special helper cells and then grew more of them in the laboratory. They then infused roughly 5 billion of the cells back into the patients without chemotherapy or the other harsh drugs. "It's a simpler and less toxic approach to melanoma than had been previously employed," said Dr. Louis Weiner, director of the cancer center at Georgetown University.
Note: For many hopeful reports on potential new cancer cures, click here.
The last thing John Kanzius thought he'd ever do was try to cure cancer. A former radio and television executive from Pennsylvania, he came to Florida to enjoy his retirement. "I have no business being in the cancer business. It's not something that a layman like me should be in, it should be left to doctors and research people," he told [CBS] correspondent Lesley Stahl. It was the worst kind of luck that gave Kanzius the idea to use radio waves to kill cancer cells: six years ago, he was diagnosed with terminal leukemia and since then has undergone 36 rounds of toxic chemotherapy. But it wasn't his own condition that motivated him, it was looking into the hollow eyes of sick children on the cancer ward at M.D. Anderson Cancer Center in Houston. "I saw the smiles of youth and saw their spirits were broken. And you could see that they were ... asking, 'Why can't they do something for me?'" Kanzius told Stahl. "And I said, 'There's got to be a better way to treat cancer.'" It was during one of those sleepless nights that the light bulb went off. When he was young, Kanzius was one of those kids who built radios from scratch, so he knew the hidden power of radio waves. Sick from chemo, he got out of bed, went to the kitchen, and started to build a radio wave machine. "Started looking in the cupboard and I saw pie pans and I said, 'These are perfect. I can modify these,'" he recalled. His wife Marianne woke up that night to a lot of banging and clamoring. "I was concerned truthfully that he had lost it," she told Stahl. "She felt sorry for me," Kanzius added. "I did," Marianne Kanzius acknowledged. "And I had mentioned to him, 'Honey, the doctors can't-you know, find an answer to cancer. How can you think that you can?'" That's what 60 Minutes wanted to know, so Stahl went to his garage laboratory to find out.
Note: This CBS News report was broadcast on 60 Minutes. To watch the video of the broadcast, click on the link above.
Vitamin D-binding protein-derived macrophage activating factor (GcMAF) appears to be an effective immunotherapeutic agent in patients with metastatic breast cancer, according to US and Japanese researchers. "Serum vitamin D-binding protein -- known as Gc protein -- is the precursor of the principal macrophage activating factor," lead investigator Dr. Nobuto Yamamoto told Reuters Health. "Treatment of purified Gc protein with beta-galactosidase and sialidase generates GcMAF," he added, "the most potent macrophage activating factor ever discovered, which produces no side effect in humans." Dr. Yamamoto of the Socrates Institute for Therapeutic Immunology, Philadelphia and colleagues note that in vitro studies show that macrophages treated with GcMAF have a highly tumoricidal effect in mammary adenocarcinomas. To investigate whether the approach can be effective in humans, the researchers studied 16 non-anemic breast cancer patients who were given "a minute amount -- 100 nanograms per week -- of GcMAF," Dr. Yamamoto said. The researchers found that after 16 to 22 GcMAF doses, initially elevated nagalase levels, which reflect the tumor burden, fell to those found in healthy controls. Follow-up over 4 years showed that the level remained low and that there was no tumor recurrence, they report in the January 15th issue of The International Journal of Cancer. The findings, the team concludes, clearly demonstrate "the importance of focusing cancer immunotherapy on macrophage activation."
Note: Another article from the National Institutes of Health website covers an experiment with colorectal cancer patients using this amazing discovery. It states that "all colorectal cancer patients exhibited healthy control levels of the serum Nagalase activity, indicating eradication of metastatic tumor cells." Why isn't this getting more major press coverage?
Today, some scientists think [that] germs can teach our bodies how to fight back against tumors. Dr. John Timmerman, a cancer immunotherapy expert at UCLA's Jonsson Cancer Center, says this revolution has produced "the most exciting sets of compounds in cancer immunology." New studies are revealing that certain cancers may be reduced by exposure to disease-causing bacteria and viruses. The studies also imply that our cleaner, infection-free lifestyles may be contributing to the rise in certain cancers over the last 50 years, scientists say, because they make the immune system weaker or less mature. Germs cause disease but may also fortify the body, a notion summed up in a 2006 report by a team of Canadian researchers as "whatever does not kill me makes me stronger." In the 1980s, dermatologists began noticing that patients with severe acne, which is caused by another type of bacterium, have reduced rates of skin cancer, lymphoma and leukemia. According to a paper by Dr. Mohammad Namazi at the Shiraz University of Medical Sciences in Iran, studies showed that these bacteria, when injected into animals, appear to stimulate the immune system and shrink tumors. In reports published in the last two years, Harvey Checkoway, a University of Washington epidemiologist, has found that female cotton workers in Shanghai have a 40% to 60% lower risk of lung, breast, and pancreas cancer than other factory workers. Other recent studies by Giuseppe Mastrangelo at the University of Padua in Italy found that dairy farmers exposed to high levels of manure dust are up to five times less likely to develop lung cancer than their colleagues who work in open fields.
Note: For exciting reports of promising new approaches to curing cancer, click here.
Last winter, inventor John Kanzius was already attempting one seemingly impossible feat -- building a machine to cure cancer with radio waves -- when his device inadvertently succeeded in another: He made saltwater catch fire. TV footage of his bizarre discovery has been burning up the blogosphere ever since, drawing crackpots and Ph.D.s alike into a raging debate. Can water burn? And if so, what good can come of it? Some people gush over the invention's potential for desalinization or cheap energy. Briny seawater, after all, sloshes over most of the planet's surface, and harnessing its heat energy could power all sorts of things. Skeptics say Kanzius's radio generator is sucking up far more energy than it's creating, making it a carnival trick at best. For now, Kanzius is tuning out the hubbub. Diagnosed with leukemia in 2002, he began building his radio-wave blaster the next year, soon after a relapse. If he could seed a person's cancerous cells with nanoscopic metal particles and blast them with radio waves, perhaps he could kill off the cancer while sparing healthy tissue. The saltwater phenomenon happened by accident when an assistant was bombarding a saline-filled test tube with radio waves and bumped the tube, causing a small flash. Curious, Kanzius struck a match. "The water lit like a propane flame," he recalls. "People said, 'It's a crock. Look for hidden electrodes in the water,' " says Penn State University materials scientist Rustum Roy, who visited [Kanzius] in his lab in August after seeing the feat on Google Video. A demo made Roy a believer. "This is discovery science in the best tradition," he says. Meanwhile, researchers at MD Anderson Cancer Center in Houston and the University of Pittsburgh Medical Center have made progress using Kanzius's technology to fight cancer in animals. They published their findings last month in the journal Cancer.
Note: For other compelling articles on this fascinating invention, see recent articles in the Los Angeles Times, ABC News, and especially Medical News Today. And for dozens of astounding major media articles showing clear suppression of potential cancer cures, click here.
In what a dying Rick Smalley called the most important application from his Nobel Prize-winning discovery [of fullerines], Houston researchers are using [carbon] nanotubes heated by radio waves to kill cancer cells. In a paper posted online by the journal Cancer, a team at the University of Texas M.D. Anderson Cancer Center and Rice University reported that the technique destroyed liver cancer tumors in rabbits and caused no side effects. It is thought to hold the same potential for many other cancers. "I don't want to overstate matters — I'm the biggest skeptic in the world — given the challenges still ahead of us," Dr. Steven Curley, an M.D. Anderson surgical oncologist and the paper's senior author, said Thursday. "But my hope is that this will be a very useful tool to safely and efficiently treat a lot of types of cancer." The therapy marries two disparate disciplines: the relatively ancient field of radio waves and nanotechnology, the cutting-edge science of the ultra-small. The rabbit study found the therapy worked only when the two were used together. It works not by poisoning but by creating a localized hyperthermia — or small fever — that destroys the cancer cells' membranes, protein and even DNA. The cells then die and are carried out of the body through normal kidney functions. In the experiment recounted in Cancer, the rabbits were injected with a solution of single-walled carbon nanotubes — hollow cylinders of pure carbon measuring about a billionth of a meter across — then exposed to two minutes of radio-frequency treatment. The result, researchers said, was the thermal destruction of 100 percent of the tumors. The idea was inspired by John Kanzius, an M.D. Anderson leukemia patient and retired Pennsylvania radio and television station owner. He developed a radio-frequency generator after undergoing chemotherapy and noting its effect on himself and other patients.
Note: For many hopeful new developments in the search for cancer cures, click here.
Sunbathing, considered risky by skin cancer experts, may actually reduce the risk of breast and other cancers, new research has found. Some women who had higher sun exposure had their risk of advanced breast cancer reduced by almost half, according to the scientific study. The researchers from Stanford University, who report their findings in the American Journal of Epidemiology this week, said: "This study supports the idea that sunlight exposure reduces risk of advanced breast cancer among women with light skin pigmentation." The Stanford cancer specialists measured 4,000 women aged 35 to 79, half of them diagnosed with breast cancer, for the effects of long-term sun exposure. Sun exposure may also protect against a number of other cancers, according to a second research team who studied more than four million people in 11 countries, including 416,000 who had been diagnosed with skin cancer. These results, reported in the European Journal of Cancer, show that the risk of internal cancers ... was lower among people living in sunny countries. The researchers said: "Vitamin D production in the skin seems to decrease the risk of several solid cancers, especially stomach, colo-rectal, liver and gall- bladder, pancreas, lung, female breast, prostate, bladder and kidney cancers." Sunlight plays a vital role in the production of beneficial vitamin D in the body. Although food provides some vitamin D, up to 90 per cent comes from exposure to sunlight.
Note: For many reliable, verifiable reports on promising cancer cures, click here.
For most, a cancer diagnosis can be devastating. But for John Kanzius it was a call to action. Kanzius isn't a doctor. He doesn't even have a college degree. Yet ... the device he invented has impressed a notable researcher and inspired his hometown, Erie, Pa., to the point where it gave him a key to the city in April. Asked by [a reporter] what made him think he could cure cancer, Kanzius replied with a laugh, "Nobody else was doing it! I envision this treatment taking no more than a couple of minutes or so." Kanzius hopes cancer treatments could work something like this: A patient would be injected with tiny metal nano-particles, which would be carried through the bloodstream by a targeting molecule and attach only to cancerous cells. The patient would then be exposed to an energy field created by radio waves, and feel nothing, while the nano-particles would generate enough heat to destroy their cancerous host cell. Kanzius demonstrated just how easily the nano-particles could be used as receivers. A lab worker injected carbon nano-particles into a specific spot in a piece of liver, which was then placed into an energy field of low frequency radio waves. Within seconds, the areas injected the with nano-particles were heated to the point of actually cooking the liver, while leaving the surrounding meat unscathed. Kanzius' invention has caught the attention of Dr. Steven Curley, a surgical oncologist and cancer researcher at MD Anderson Cancer Center in Houston. "This has the most fascinating potential I've seen in anything in my twenty years of cancer research," Curley [said]. Curley has developed current methods of using radio frequencies to attack cancer, but says he looks forward to one day using a non-invasive approach like the one Kanzius is working on.
Note: For a treasure trove of reliable information about exciting possible cancer cures, click here.
In laboratory experiments, a team at the University of Glasgow simulated what happens in the human stomach. They found vitamin C (ascorbic acid) mopped up potential cancer-causing compounds that are made when saliva and food mixes with stomach acid. But when they added fat to the mix, the ascorbic acid could no longer convert the hazardous compounds into safe ones. Antioxidants like ascorbic acid protect against the formation of (carcinogenic) nitrosocompounds by converting the nitrosating species into nitric oxide. However, when fat is present, it reacts with the nitric oxide to reform nitrosating species, the scientists found. Bridget Aisbitt, nutrition scientist for the British Nutrition Foundation, said: ... "This research is interesting." She said fat-compatible antioxidants in the body, such as beta-carotene, could also neutralise the nitrosocompounds. This is another reason to underline the importance of a healthy balanced diet where meals high in fat should not be frequent and five portions of fruit and vegetables - our main source of vitamin C - are eaten each day.
Note: Why isn't it being widely reported the Vitatmin C and beta-carotene are effective cancer fighters? For a possible answer by one of the top physicians in the U.S., click here.
We could make faster progress against cancer by changing the way drugs are developed. In the current system, if a promising compound can’t be patented, it is highly unlikely ever to make it to market — no matter how well it performs in the laboratory. The development of new cancer drugs is crippled as a result. The reason for this problem is that bringing a new drug to market is extremely expensive. In 2001, the estimated cost was $802 million; today it is approximately $1 billion. To ensure a healthy return on such staggering investments, drug companies seek to formulate new drugs in a way that guarantees watertight patents. In the meantime, cancer patients miss out on treatments that may be highly effective and less expensive to boot. In 2004, Johns Hopkins researchers discovered that an off-the-shelf compound called 3-bromopyruvate could arrest the growth of liver cancer in rats. The results were dramatic; moreover, the investigators estimated that the cost to treat patients would be around 70 cents per day. Yet, three years later, no major drug company has shown interest in developing this drug. The hormone melatonin, sold as an inexpensive food supplement in the United States, has repeatedly been shown to slow the growth of various cancers when used in conjunction with conventional treatments. Early this year, another readily available industrial chemical, dichloroacetate, was found by researchers at the University of Alberta to shrink tumors in laboratory animals by up to 75 percent. However ... dichloroacetate is not patentable, and the lead researcher is concerned that it may be difficult to find funding from private investors to test the chemical. Potential anticancer drugs should be judged on their scientific merit, not on their patentability.
Note: To explore several cancer cures which have shown dramatic potential, yet are not being studied for lack of funds due to inability to patent the process, click here. Why are these very promising treatments not being fast-tracked as the expensive AIDS drugs were? For a top MD's revealing comments on this, click here. And for why the media won't feature these promising cancer treatments in headlines, click here.
A Florida man with no medical training has invented a machine that he believes may lead to a cure for cancer. John Kanzius ... wondered if his background in physics and radio could come in handy in treating the disease from which he suffers himself. After 24 rounds of chemotherapy, the former broadcaster decided that he did not want to see others suffer trying to cure the disease. Kanzius said it was watching kids being treated that affected him the most. "Particularly, young children walk in with smiles, and then you'd see them three weeks later and their smiles had disappeared. I said to myself, 'We're in a barbaric type of medicine." Kanzius said his machine basically makes cells act like antennae to pick up a signal and self-destruct. Unlike current cancer treatment, Kanzius' machine does not use radiation, and unlike today's radio-frequency treatments, it's noninvasive. Now, some of the nation's most prominent doctors and scientists are using Kanzius' machines in their research. In January, researchers said they performed a breakthrough at the M. D. Anderson Cancer Center in Houston. "The complete killing of pancreatic cells in laboratory conditions is encouraging," Dr. Steve Curley said. Kanzius explained that his machine uses a solution filled with nanoparticles, which measure no more than one-billionth of a meter. A test subject would be injected with either gold or carbon nanoparticles, which would make their way through the body and attach to the cancerous cells. The test subject would then enter the machine and receive a dose of radio frequency waves, theoretically heating and killing the cancerous cells in moments and leaving nearby cells untouched.
There are no magic bullets in the fight against cancer: that's the first thing every responsible scientist mentions when discussing a possible new treatment, no matter how promising. If there were a magic bullet, though, it might be something like dichloroacetate, or DCA, a drug that kills cancer cells by exploiting a fundamental weakness found in a wide range of solid tumors. So far, though, it kills them just in test tubes and in rats infected with human cancer cells; it has never been tested against cancer in living human beings. DCA ... is an existing drug whose side effects are well-studied and relatively tolerable. Also, it's a small molecule that might be able to cross the blood-brain barrier to reach otherwise intractable brain tumors. Within days after a technical paper on DCA appeared in the journal Cancer Cell last week, the lead author, Dr. Evangelos Michelakis of the University of Alberta, was deluged with calls and e-mails from prospective patients—to whom he can say only, “Hang in there.” DCA is a remarkably simple molecule. It acts in the body to promote the activity of the mitochondria. Researchers have assumed that the mitochondria in cancer cells were irreparably damaged. But Michelakis wondered if that was really true. With his colleagues he used DCA to turn back on the mitochondria in cancer cells—which promptly died. One of the great things about DCA is that it's a simple compound, in the public domain, and could be produced for pennies a dose. But that's also a problem, because big drug companies are unlikely to spend a billion dollars or so on large-scale clinical trials for a compound they can't patent.
Note: Read a 2010 follow-up by Dr. Michelakis with promising results and watch a 10-minute video. Explore the DCA website. Why didn't other mass media report this major story? Why aren't many millions of dollars being poured into research? Notice even Newsweek acknowledges the drug companies are not interested in finding a cure for cancer if they can't make a profit from it. Some suspect the drug companies have even suppressed cancer cures found in the past. See one amazing example of this. For more, see these major media articles on potential cancer cures.
In results that "astounded" scientists, an inexpensive molecule known as DCA was shown to shrink lung, breast and brain tumours in both animal and human tissue experiments. The study was published yesterday in the journal Cancer Cell. "I think DCA can be selective for cancer because it attacks a fundamental process of cancer that is unique to cancer cells," said Dr. Evangelos Michelakis, a professor at the Edmonton university's medical school and one of the study's key authors. The molecule appears to repair damaged mitochondria in cancer cells. "When a cell is getting too old or doesn't function properly, the mitochondria are going to induce the cell death," lead study author Sebastien Bonnet said yesterday. Bonnet says DCA – or dichloroacetate – appears to reverse the mitochondrial changes in a wide range of cancers. "One of the really exciting things about this compound is that it might be able to treat many different forms of cancer because all forms of cancer suppress mitochondrial function," Michelakis said. Bonnet says DCA may also provide an effective cancer treatment because its small size allows easy absorption into the body, ensuring it can reach areas that other drugs cannot, such as brain tumours. Because it's been used to combat other ailments ... DCA has been shown to have few toxic effects on the body. Its previous use means it can be immediately tested on humans. Unlike other cancer drugs, DCA did not appear to have any negative effect on normal cells. It could provide an extremely inexpensive cancer therapy because it's not patented. But ... the lack of a patent could lead to an unwillingness on the part of pharmaceutical companies to fund expensive clinical trials.
Note: Even these scientists realize that though this discovery could be a huge benefit to mankind, because the drug companies will lose profits, they almost certainly will not fund studies. Expensive AIDS drugs with promising results, on the other hand, are rushed through the studies to market. For more reliable, verifiable information on how hugely beneficial health advances are shut down to keep profits high, click here and here.
A Toronto-led team of researchers has discovered a trigger for Type 1 diabetes, a breakthrough that has long evaded scientists and could lead the way to preventing the disease. The team found that abnormal nerve endings in the insulin-producing cells of the pancreas initiated a chain of events that caused Type 1 diabetes in mice. When they removed the nerve cells, the mice did not develop the disorder. That means diabetes may be a disease of the nervous system, not just an autoimmune disease, said Dr. Hans Michael Dosch, a senior scientist at the Hospital for Sick Children and the study's main investigator. In a reversal of what they expected, the researchers also found injecting substance P — a chemical secreted by nerve cells — into mice whose islet cells were inflamed and on the way to being destroyed not only eliminated the inflammation but reversed it. "The blood glucose normalizes overnight and it stays low for weeks to months — this is with a single shot," Dosch said. "We now have 4-month-old mice that are non-diabetic that used to be diabetic" — a period equivalent to six to eight years in humans. Experts say the findings, reported yesterday in the journal Cell, will change the way scientists think about diabetes. "It really is a breakthrough for the diabetes community," said Pam Ohashi, a professor of immunology at the University of Toronto. Dosch has immediate plans to move his research from mice to humans. He is launching a clinical trial in January to figure out if patients who have a high risk of Type 1 diabetes have the same sensory nerve abnormalities. "If they do, then we have fantastic new therapeutic strategies," said Dosch, who is also a professor of pediatrics and immunology at U of T.
Note: The pharmaceutical industry makes huge profits from diabetics. Big profits have been known to prevent cures from making it to market. Click here for more. Let's hope this important research moves forward.
Important Note: Explore our full index to key excerpts of revealing major media news articles on several dozen engaging topics. And don't miss amazing excerpts from 20 of the most revealing news articles ever published.